Previous 10 | Next 10 |
In my previous article I outlined reasons Rockwell Medical ( RMTI ) was worth considering as a speculative investment. Since then, Rockwell's risk could decrease significantly if the CMS approves a separate J-code for powdered Triferic as announced. If approved, dialysis centers - that are...
WIXOM, Mich., May 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a global biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal diseas...
WIXOM, Mich., May 02, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter financial results on Thursday, May 9, 2019, after the closing of the U.S. financial m...
WIXOM, Mich., May 01, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company"), a global biopharmaceutical company dedicated to improving outcomes for patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the Centers for Med...
With the first quarter of 2019 officially over, the end of each quarter represents an opportune time to reflect on the top performing stocks of each industry — including the pharmaceuticals sector. Throughout Q1 2019, drug pricing remained a constant topic of conversation, even in Con...
WIXOM, Mich., April 03, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the H.C Wainwright Global Life Sciences Conference as follows: The presentation will be w...
The following slide deck was published by Rockwell Medical, Inc. in conjunction with this Read more ...
WIXOM, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the Sidoti & Company LLC Spring 2019 Investor Conference as follows: The presentatio...
I.V. Triferic Data to Support Upcoming New Drug Application Intraperitoneal Triferic Effectively Delivers Iron to Patients with Kidney Failure in Outpatient Setting WIXOM, Mich., March 18, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) (“Rockwell Medi...
Rockwell Medical's (RMTI) Q4 2018 Results Earnings Conference Call March 14, 2019, 08:30 AM ET Company Participants Judy DiClemente - In-Site Communications Stuart Paul - President and CEO Angus Smith - CFO Conference Call Participants David Bouchey - IFS Securities Pres...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...